The connections between anti-VEGF medications and various aspects of renal glomerular and tubular dysfunction, including proteinuria, hypertension, and electrolyte imbalances, are subjects of promising translational research [5, 6]. The gene discussed is VEGFA; the disease is hypertensive disorder.